InvestorsHub Logo

TheDane

12/26/18 2:05 PM

#252680 RE: DaubersUP #252678

It’s would nice if this kind of thing was happening behind the scenes with IPIX and Companies, A, B, C and D.

You highlighted all the right “G” spots. I like the part where the company was contacted shortly after receiving the EOP1 meeting minutes from the FDA. It’s amazing how many times the offer was raised.

To dream the impossible dream!

Blue Fin

12/26/18 2:31 PM

#252681 RE: DaubersUP #252678

Here is hoping there is a Novartis, in our future. Once they got into the game there was no going back. great info Daubers UP, thanks for that!

zandant

12/26/18 3:24 PM

#252682 RE: DaubersUP #252678

Thanks Daubers. Very interesting read. While I understand that the purpose of providing this article was to demonstrate the process of a potential merger or licensing agreement, to view this in the context of IPIX is like comparing a barrel of fresh, juicy oranges that are highly desired to a crate of old, beginning to rot apples that the seller may be pushing but upon close inspection, nobody wants to buy. Just right off the bat, I am assuming, perhaps incorrectly but I doubt it, that the company with the desired drug had a competent CEO and management team and a legitimate Board. I do not see that with IPIX. Also, the stock price initially was around $81 dollars and the merger brought a $218 value to the pps, almost 3 times over the pps. Three times over IPIX's pps would be 24 cents.